🔎 Trials Near Me

Dachaigh › Galar Depressive Mòr › Florida › Orlando

Sgrùdaidhean clionaigeach Galar Depressive Mòr ann an Orlando, FL

Tha 19 sgrùdaidhean airson Galar Depressive Mòr a’ lorg phàirtichean aig làraichean ann agus timcheall air Orlando (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

A’ fastadhÌre 3
  • Nova Psychiatry INC, Orlando
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

A’ fastadhÌre 2
  • Clinical Neuroscience Solutions Inc. - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

A’ fastadhÌre 3
  • Accel Research Sites - Maitland, Maitland · 6 mìle air falbh
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

A’ fastadhÌre 2
  • Seaport Investigator Site, Orlando
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

A’ fastadhÌre 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07284667

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

A’ fastadhÌre 2
  • Draig Clinical Site, Orlando
  • Draig Clinical Site, Orlando
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

A’ fastadhÌre 2
  • Draig Clinical Site, Orlando
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07300969

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

A’ fastadhÌre 3
  • Clinical Neuroscience Solutions, LLC (Orlando), Orlando
  • Charter Research, Orlando
  • K2 Medical Research (Maitland), Maitland · 6 mìle air falbh
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07592689

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A’ fastadhÌre 3
  • Neurocrine Clinical Site, Maitland · 6 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

A’ fastadhÌre 3
  • Charter Research - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mìle air falbh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

A’ fastadhÌre 3
  • Clinical Neuroscience Solutions, Inc., Orlando
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

A’ fastadhÌre 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06547489

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A’ fastadhÌre 3
  • Neurocrine Clinical Site, Orlando
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A’ fastadhÌre 3
  • Neurocrine Clinical Site, Maitland · 6 mìle air falbh
  • Neurocrine Clinical Site, Maitland · 6 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

A’ fastadhÌre 2
  • Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 15 Ògmh 2026 · NCT07276997

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A’ fastadhÌre 3
  • Neurocrine Clinical Site, Maitland · 6 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Dàmh 2025 · NCT06786624

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

A’ fastadh
  • AdventHealth Neuroscience Institute, Orlando
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 22 Dàmh 2025 · NCT05877885

Study of ALTO-300 in MDD

A’ fastadhÌre 2
  • Site 159, Clermont · 24 mìle air falbh
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Iuch 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

A’ fastadhÌre 4
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 23 Faoi 2025 · NCT06223880

Sgrùdaidhean Galar Depressive Mòr ann am bailtean eile

Sgrùdaidhean eile ann an Orlando

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.